By using F98 and U87 human glioma cells, the authors showed that the decreased KEAP1 or enhanced NRF2 expression fostered both cell proliferation and colony-forming activity, strongly increasing the mRNA and protein levels of the xCT antiporter and promoting resistance to ferroptosis. The gene discussed is NFE2L2; the disease is central nervous system cancer.